BrightOwl Loader Loading


Strong background in cellbiology, general immunology and cell-mediated immunology as well as relevant experience in anti-cancer therapies, including oncolytic viruses, immunotherapies,anti-cancer vaccines and nanotechnology (as a (targeted) delivery mechanism for drugs or vaccines). Trained in (pre)clinical assessment of anti-cancer vaccines, with relevant experience in evaluating promising anti-cancer technologies with strong business potential. Work-related ICT enthousiast (managing intelligence biotech databases such as Biomedtracker, Medtrack and Datamonitor as well managing company article databases eg Mendeley for teams).


Current Experience

  • Analyst
    Since January 2015
    - Analyze new investment opportunities in the field of anticancer therapies (oncolytic viruses, vaccines, immunotherapy, metabolic approaches, etc) - Map biomedical anti-cancer therapies and technologies (by attending (inter)-national congresses & meetings, networking, using biomedical knowledge databases, going through relevant publications & clinical trials, going through granted/provisional patent applications etc) - Manage evaluation / content / knowledge database - Work-related ICT manager

Past Experience

  • Technology Developer
    June 2013 --- December 2014
    More specifically my work at PX Biosolutions entagled managing and driving preclinical experiments concerning PoC, safety-toxicity and immunogenicity and other IND enabling studies for a cancer vaccine (DCtag) against ovarian cancer. Concurrently, I assessed and reviewed new anti-cancer therapies that might be of interest to DROIA (biotech private investor) for further funding and/or involvement.

  • PhD researcher
    August 2008 --- June 2013
    My research focuses on establishing reference values on several immunological attributes in cats. Focus lies on regulatory cell types such as NK cells and Tregs. These reference values are then compared to values obtained in cats infected with feline coronaviruses (FECV and FIPV) to obtain more knowledge on the impact of these viruses on the feline immune system.

  • Maintenance engineer
    July 2007 --- August 2007


LinkedIn Assessment :
ImmunologyCellFlow CytometryCell CultureELISACell biologyImmunohistochemistry (IHC)Vaccinesmolecular biologyPCRImmunocytochemistry (ICC)ImmunofluorescenceMicroscopyIn VitroCell Based AssaysFluorescence MicroscopyVirologyCancer TreatmentPre-clinical StudiesClinical DevelopmentTechnology Needs Analysis


  • Doctor of Philosophy (PhD) in Veterinary Microbiology and Immunobiology from Universiteit Gent in 2013
  • Bioscience engineer in Biosciences from Universiteit Gent in 2008
  • moderne talen wiskunde in ASO from Broederschool Sint-Niklaas in 2002

Area / Region

Wetteren, Belgium


Driving License
  • No